drugset / Trial / NCT01876186
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate whether prolonged period of treatment (6 months) can have a better therapeutic outcome than conventional period (3 months) of antimuscarinics.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solifenacin | Small molecule | 5 mg | — |